Join us for “Treating Early-Stage Alzheimer’s Disease: Newly Available Treatments and What They Mean for Patients.” This hour-long online session features two leading doctors, a representative from BrightFocus, and a person with AD who will help caregivers and patients understand newly approved therapies that treat Alzheimer’s disease (AD) itself, not just the symptoms.
Topics:
- What is early Alzheimer’s disease?
- How is Alzheimer’s different from normal aging?
- Why early diagnosis is important?
- New therapies for Alzheimer’s
- How new treatments work
- Choosing the right treatment for you or your loved one
- Shared decision-making with your care team
About BrightFocus Foundation
BrightFocus Foundation is a premier global nonprofit funder of research to defeat Alzheimer’s, macular degeneration, and glaucoma. Through its flagship research programs — Alzheimer’s Disease Research, Macular Degeneration Research, and National Glaucoma Research— the Foundation has awarded nearly $300 million in groundbreaking research funding over the past 51 years and shares the latest research findings, expert information, and resources to empower the millions impacted by these devastating diseases. Learn more at brightfocus.org.
Disclaimer: The information provided here is a public service of BrightFocus Foundation and is not intended to constitute medical advice. Please consult your physician for personalized medical, dietary, and/or exercise advice. Any medications or supplements should only be taken under medical supervision. BrightFocus Foundation does not endorse any medical products or therapies.
- Treatments